ReviewArchives of toxicology2025
Formaldehyde and asthma: a plausibility?
Review in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Formaldehyde (FA) is a ubiquitous indoor air pollutant emitted from construction, consumer, and combustion-related products, and ozone-initiated reactions with reactive organic volatiles. The derivation of an indoor air quality guideline for FA by World Health Organization in 2010 did not find convincing evidence for bronchoconstriction-related reactions as detrimental lung function. Causal relationship between FA and asthma has since been advocated in meta-analyses of selected observational studies. In this review, findings from controlled human and animal exposure studies of the airways, data of FA retention in the respiratory tract, and observational studies of reported asthma applied in meta-analyses are analyzed together for coherence of direct association between FA and asthma. New information from both human and animal exposure studies are evaluated together with existing literature and assessed across findings from observational studies and associated meta-analyses thereof. Retention of FA in the upper airways is > 90% in agreement with mice exposure studies that only extreme FA concentrations can surpass trachea, travel to the lower airways, and cause mild bronchoconstriction. However, taken together, detrimental lung function effects in controlled human exposure studies have not been observed, even at FA concentrations up 4 ppm (5 mg/m
Indexed as
Identifiers
39828805What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.